Aegerion Pharmaceuticals Inc (AEGR) financial statements (2020 and earlier)

Company profile

Business Address ONE MAIN STREET
CAMBRIDGE, MA 02142
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2016
Q3
6/30/2016
Q2
3/31/2016
Q1
12/31/2015
Q4
9/30/2015
Q3
6/30/2015
Q2
3/31/2015
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments32464365728367
Cash and cash equivalents32464365728367
Receivables891114182420
Inventory, net of allowances, customer advances and progress billings42445559575945
Inventory42445559575945
Other undisclosed current assets3939393938109
Total current assets:121138147176185175142
Noncurrent Assets
Property, plant and equipment5455555
Intangible assets, net (including goodwill)228233247253259264279
Goodwill  10109913
Intangible assets, net (excluding goodwill)228233238243250255266
Deferred costs     5 
Other noncurrent assets10115613
Other undisclosed noncurrent assets     (5) 
Total noncurrent assets:233238253258268274297
TOTAL ASSETS:354376400434453450439
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities50544562625948
Accounts payable10591111107
Accrued liabilities40493651413832
Employee-related liabilities    1098
Interest and dividends payable    131
Debt33     
Estimated litigation liability414040    
Other undisclosed current liabilities2525252514(11)(9)
Total current liabilities:11912211087764839
Noncurrent Liabilities
Long-term debt and lease obligation24624123523022922425
Long-term debt, excluding current maturities24624123523022922425
Liabilities, other than long-term debt1212332
Other liabilities1212332
Other undisclosed noncurrent liabilities     25219
Total noncurrent liabilities:248242237232232252247
Total liabilities:367365347319308300286
Stockholders' equity
Stockholders' equity attributable to parent(13)1153116145150153
Common stock0000000
Treasury stock, value(35)(35)(35)(35)(35)(35)(35)
Additional paid in capital531528523519512507500
Accumulated other comprehensive income (loss)(1)(1)(0)0(0)(0)(1)
Accumulated deficit(508)(481)(434)(369)(332)(322)(311)
Total stockholders' equity:(13)1153116145150153
TOTAL LIABILITIES AND EQUITY:354376400434453450439

Income statement (P&L) ($ in millions)

9/30/2016
Q3
6/30/2016
Q2
3/31/2016
Q1
12/31/2015
Q4
9/30/2015
Q3
6/30/2015
Q2
3/31/2015
Q1
Revenues
(Revenue, Net)
35453649676459
Cost of revenue
(Cost of Goods and Services Sold)
(14)(23)(15)(11)(14)(14)(12)
Gross profit:22212138535047
Operating expenses(40)(61)(80)(66)(55)(55)(57)
Other undisclosed operating income (loss)   (1)  0
Operating loss:(19)(39)(59)(29)(2)(5)(9)
Nonoperating income (expense)001(0)010
Foreign currency transaction gain, before tax   0   
Other nonoperating income (expense)001(0)010
Interest and debt expense(8)(7)(7)(6)(7)(7)(7)
Loss from continuing operations before equity method investments, income taxes:(26)(47)(65)(35)(9)(11)(16)
Other undisclosed loss from continuing operations before income taxes   (0)   
Loss from continuing operations before income taxes:(26)(47)(65)(36)(9)(11)(16)
Income tax expense(0)(0)(0)(1)(0)(0)(0)
Net loss available to common stockholders, diluted:(27)(47)(66)(37)(10)(11)(16)

Comprehensive Income ($ in millions)

9/30/2016
Q3
6/30/2016
Q2
3/31/2016
Q1
12/31/2015
Q4
9/30/2015
Q3
6/30/2015
Q2
3/31/2015
Q1
Net loss:(27)(47)(66)(37)(10)(11)(16)
Comprehensive loss:(27)(47)(66)(37)(10)(11)(16)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(0)(0)(0)0(0)0(0)
Comprehensive loss, net of tax, attributable to parent:(27)(47)(66)(36)(10)(11)(16)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: